Loading...
Loading...
Go to the dataset
https://figshare.com/articles/dataset/source_code_for_EMO/29578388Contributors:
Dataset URI:
10.6084/m9.figshare.29578388.v3Non-coding mutations play a critical role in regulating gene expression, yet predicting their effects across diverse tissues and cell types remains a challenge. Here, we present EMO, a transformer-based model that integrates DNA sequence with chromatin accessibility data (ATAC-seq) to predict the regulatory impact of non-coding single nucleotide polymorphisms (SNPs) on gene expression. A key component of EMO is its ability to incorporate personalized functional genomic profiles, enabling individual-level and disease-contextual predictions, and addressing critical limitations of current approaches. EMO generalizes across tissues and cell types by modeling both short- and long-range regulatory interactions and capturing dynamic gene expression changes associated with disease progression. In benchmark evaluations, the pretraining-based EMO framework outperformed existing models, with fine-tuning small-sample tissues enhancing the model's ability to fit target tissues. In single-cell contexts, EMO accurately identified cell-type-specific regulatory patterns and successfully captured the effects of disease-associated SNPs in conditions, linking genetic variation to disease-relevant pathways.
Keyword(s):
Genomics; Non-coding mutations.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)
Go to the dataset
https://figshare.com/articles/dataset/source_code_for_EMO/29578388